ELITRA PHARMACEUTICALS INC.
THIRD AMENDED AND RESTATED RIGHT OF FIRST OFFER
AND
CO-SALE AGREEMENT
THIS THIRD AMENDED AND RESTATED RIGHT OF FIRST OFFER AND CO-SALE
AGREEMENT (the "Agreement") is made as of this 18th day of August, 2000, by
and among ELITRA PHARMACEUTICALS INC., a Delaware corporation (the
"Company"), the holders of the Company's Series A Preferred Stock listed on
EXHIBIT A hereto, the holders of the Company's Series B Preferred Stock
listed on EXHIBIT A hereto, the holder of the Company's Series C Preferred
Stock listed on EXHIBIT A hereto, the holder of the Company's Series D
Preferred Stock listed on EXHIBIT A hereto, the holders of the Company's
Series E Preferred Stock listed on EXHIBIT A hereto (collectively, the
"Investors"), and certain holders of the Company's Common Stock listed on
EXHIBIT B hereto (collectively with the Investors, the "Stockholders").
RECITALS
WHEREAS, certain of the Investors hold shares of the Company's
Series A Preferred Stock (the "Series A Preferred Stock"), shares of the
Company's Series B Preferred Stock (the "Series B Preferred Stock"), shares
of the Company's Series C Preferred Stock (the "Series C Preferred Stock")
and shares of the Company's Series D Preferred Stock (the "Series D Preferred
Stock"), and possess certain rights of first offer and co-sale rights
pursuant to an existing Second Amended and Restated Right of First Offer and
Co-Sale Agreement dated as of June 30, 2000 by and among the Company, certain
holders of the Company's Common Stock and such Investors (the "Prior
Agreement");
WHEREAS, the undersigned Investors who hold Series A Preferred
Stock, Series B Preferred Stock, Series C Preferred Stock and Series D
Preferred Stock hold more than sixty-six and two-thirds percent (66 2/3%) in
interest of the Common Stock or securities convertible into Common Stock held
by the Investors (as defined in the Prior Agreement) and the undersigned
Stockholders who hold Series A Preferred Stock, Series B Preferred Stock,
Series C Preferred Stock, Series D Preferred Stock and Common Stock hold more
than sixty-six and two-thirds percent (66 2/3%) in interest of the Common
Stock or securities convertible into Common Stock held by the Stockholders
(as defined in the Prior Agreement), and such Investors and the Company
desire to terminate the Prior Agreement and to accept the rights created
pursuant hereto in lieu of the rights granted to them under the Prior
Agreement, with the Prior Agreement being superseded and of no further force
or effect as of the date hereof;
WHEREAS, certain Investors are purchasing shares of the Company's
Series E Preferred Stock (the "Series E Preferred Stock") and warrants to
purchase shares of Series E Preferred Stock (the "Warrants") pursuant to that
certain Series E Preferred Stock and Warrant Purchase Agreement (the
"Purchase Agreement") dated as of the date hereof, among such Investors and
the Company;
1.
WHEREAS, such Investors were induced by the Company to purchase the
Series E Preferred Stock and the Warrants in part by the Company's and the
Stockholders' agreement to enter into this Agreement; and
WHEREAS, the parties desire to enter into this Agreement in order to
grant rights of first offer to each Stockholder and rights of co-sale to each
Investor.
NOW, THEREFORE, in consideration of the mutual covenants set forth
herein, the parties hereto agree as follows:
1. DEFINITIONS.
1.1 "STOCKHOLDER STOCK" shall mean shares of the Company's Common
Stock, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred
Stock, Series D Preferred Stock and Series E Preferred Stock now owned or
subsequently acquired by the Stockholders by gift, purchase, dividend, option
exercise, warrant exercise or any other means whether or not such securities
are only registered in a Stockholder's name or beneficially or legally owned
by such Stockholder, including any interest of a spouse in any of the
Stockholder Stock, whether that interest is asserted pursuant to marital
property laws or otherwise. The number of shares of Stockholder Stock owned
by the Stockholders as of the date hereof is set forth on EXHIBIT A and
EXHIBIT B, which Exhibits may be amended from time to time by the Company to
reflect changes in the number of shares owned by the Stockholders, but the
failure to so amend shall have no effect on such Stockholder Stock being
subject to this Agreement.
1.2 "INVESTOR STOCK" shall mean the shares of the Company's Common
Stock now owned or subsequently acquired by the Investors whether or not such
securities are only registered in an Investor's name or beneficiary or
otherwise legally owned by such Investor.
1.3 "COMMON STOCK" shall mean the Company's Common Stock and
shares of Common Stock issued or issuable upon conversion of the Company's
outstanding preferred stock or exercise of any option, warrant or other
security or right of any kind convertible into or exchangeable for Common
Stock.
1.4 For purposes of this Agreement, the term "TRANSFER" shall
include any sale, assignment, encumbrance, hypothecation, pledge, conveyance
in trust, gift, transfer by request, devise or descent, or other transfer or
disposition of any kind, including, but not limited to, transfers to
receivers, levying creditors, trustees or receivers in bankruptcy proceedings
or general assignees for the benefit of creditors, whether voluntary or by
operation of law, directly or indirectly, of any of the Stockholder Stock.
2. TRANSFERS BY A STOCKHOLDER.
2.1 NOTICE OF TRANSFER. If a Stockholder (a "SELLING STOCKHOLDER")
proposes to Transfer any shares of Stockholder Stock, such Selling
Stockholder shall provide the applicable form of notice, as set forth below.
(a) If a Selling Stockholder proposes to Transfer shares of
Stockholder Stock to another Stockholder then the Selling Stockholder shall
promptly give written notice (the
2.
"NOTICE") simultaneously to the Company and to each of the other Stockholders
at least thirty (30) days prior to the closing of such Transfer. The Notice
shall describe in reasonable detail the proposed Transfer including, without
limitation, the number of shares of Stockholder Stock to be transferred, the
nature of such Transfer, the consideration to be paid, and the name and
address of each prospective purchaser or transferee. In the event that the
Transfer is being made pursuant to the provisions of Section 3(a), the Notice
shall state under which section the Transfer is being made.
(b) If a Selling Stockholder proposes to Transfer shares of
Stockholder Stock to any person or entity who is not a Stockholder then the
Selling Stockholder shall promptly give the CO-SALE NOTICE specified in
Section 2.3 hereof, and the procedures set forth in Section 2.2 shall be
inapplicable to such transfer.
2.2 STOCKHOLDER RIGHT OF FIRST OFFER.
(a) With respect to any Transfer of shares of Stockholder Stock by a
Selling Stockholder to another Stockholder (the "PROPOSED STOCKHOLDER
TRANSFEREE"), each Stockholder (other than the Selling Stockholder and the
Proposed Stockholder Transferee) shall have the right, exercisable upon
written notice to the Selling Stockholder (the "STOCKHOLDER NOTICE") within
ten (10) days after the receipt of the Stockholder Notice, to purchase its
PRO RATA share of the Stockholder Stock subject to the Stockholder Notice and
on the same terms and conditions as set forth therein. The Stockholders who
so exercise their rights (the "PARTICIPATING STOCKHOLDERS") shall effect the
purchase of the Stockholder Stock, including payment of the purchase price,
not more then five (5) days after delivery of the Stockholder Notice, and at
such time the Stockholder shall deliver to the Stockholders the
certificate(s) representing the Stockholder Stock to be purchased by the
Participating Stockholders, each certificate to be properly endorsed for
transfer.
(b) Each Stockholder's PRO RATA share shall be equal to the product
obtained by multiplying (x) the aggregate number of shares of Stockholder
Stock covered by the Stockholder Notice and (y) a fraction, the numerator of
which is the number of shares of Common Stock owned by the Participating
Stockholder at the time of the Transfer and the denominator of which is the
total number of shares of Common Stock owned by all of the Stockholders
(other than the Selling Stockholders) at the time of the Transfer.
2.3 RIGHT OF CO-SALE.
(a) In the event that (i) the Stockholders fail to exercise their
right to purchase all of the Stockholder Stock subject to the Right of First
Offer, following the exercise or expiration of the right of purchase set
forth in Section 2.2, or (ii) a Selling Stockholder proposes to Transfer
shares of Stockholder Stock to any person or entity who is not a Stockholder,
then the Selling Stockholder shall deliver to the Company and each Investor
written notice (the "CO-SALE NOTICE") that each Investor shall have the
right, exercisable upon written notice to such Selling Stockholder within
fifteen (15) days after receipt of the Co-Sale Notice, to participate in such
Transfer of Stockholder Stock on the same terms and conditions. Such notice
shall indicate the number of shares of Investor Stock such Investor wishes to
sell under his or her right to participate. To the extent one or more of the
Investors exercise such right of participation in
3.
accordance with the terms and conditions set forth below, the number of
shares of Stockholder Stock that the Selling Stockholder may sell in the
transaction shall be correspondingly reduced.
(b) Each Investor may sell all or any part of that number of shares
equal to the product obtained by multiplying (i) the aggregate number of
shares of Stockholder Stock covered by the Co-Sale Notice by (ii) a fraction
the numerator of which is the number of shares of Common Stock owned by such
Investor at the time of the Transfer and the denominator of which is the
total number of shares of Common Stock owned by such Selling Stockholder and
the Investors at the time of the Transfer.
(c) Each Investor who elects to participate in the Transfer
pursuant to this Section 2.3 (a "CO-SALE PARTICIPANT") shall effect its
participation in the Transfer by promptly delivering to the Selling
Stockholder for transfer to the prospective purchaser one or more
certificates, properly endorsed for transfer, which represent:
(i) the type and number of shares of Common Stock which such
Co-Sale Participant elects to sell; or
(ii) that number of shares of Preferred Stock which is at such
time convertible into the number of shares of Common Stock which such Co-Sale
Participant elects to sell; provided, however, that if the prospective
purchaser objects to the delivery of Preferred Stock in lieu of Common Stock,
such Co-Sale Participant shall convert such Preferred Stock into Common Stock
and deliver Common Stock as provided in Section 2.3(c)(i) above. The Company
agrees to make any such conversion concurrent with the actual transfer of
such shares to the purchaser.
(d) The stock certificate or certificates that the Co-Sale
Participant delivers to the Selling Stockholder pursuant to Section 2.3(c)
shall be transferred to the prospective purchaser in consummation of the sale
of the Common Stock pursuant to the terms and conditions specified in the
Co-Sale Notice, and the Selling Stockholder shall concurrently therewith
remit to such Co-Sale Participant that portion of the sale proceeds to which
such Co-Sale Participant is entitled by reason of its participation in such
sale. To the extent that any prospective purchaser or purchasers prohibits
such assignment or otherwise refuses to purchase shares or other securities
from a Co-Sale Participant exercising its rights of co-sale hereunder, such
Selling Stockholder shall not sell to such prospective purchaser or
purchasers any Stockholder Stock unless and until, simultaneously with such
sale, such Selling Stockholder shall purchase such shares or other securities
from such Co-Sale Participant on the same terms and conditions specified in
the Co-Sale Notice.
(e) The exercise or non-exercise of the rights of the Investors
hereunder to participate in one or more Transfers of Stockholder Stock made
by the Selling Stockholder shall not adversely affect their rights to
participate in subsequent Transfers of Stockholder Stock subject to Section
2.1.
(f) If none of the Investors elect to participate in the sale of
the Stockholder Stock subject to the Co-Sale Notice, such Selling Stockholder
may, not later than sixty (60) days following delivery to the Company of the
Co-Sale Notice, enter into an agreement providing for
4.
the closing of the Transfer of the Stockholder Stock covered by the Co-Sale
Notice within thirty (30) days of such agreement on terms and conditions not
more materially favorable to the transferor than those described in the
Co-Sale Notice. Any proposed Transfer on terms and conditions materially more
favorable than those described in the Co-Sale Notice, as well as any
subsequent proposed Transfer of any of the Stockholder Stock by a Selling
Stockholder, shall again be subject to the first refusal and co-sale rights
of the Stockholders or Investors and shall require compliance by a Selling
Stockholder with the procedures described in this Section 2.
3. EXEMPT TRANSFERS.
(a) Notwithstanding the foregoing, the foregoing right of first offer of
the Stockholders and co-sale rights of the Investors shall not apply to (i)
any transfer or transfers by a Stockholder which in the aggregate, over the
term of this Agreement, amount to no more than fifty thousand (50,000) shares
of Stockholder Stock held by a Stockholder as of the date hereof (as adjusted
for stock splits, dividends and the like), (ii) any transfer to the
ancestors, descendants or spouse of the Stockholder or to trusts for the
benefit of such persons or the Stockholder, (iii) a transfer by a Stockholder
which is (A) a partnership to either its partners or former partners in
accordance with partnership interests, or to its affiliated entities, (B) a
corporation to its shareholders in accordance with their interest in the
corporation, or (C) a limited liability company to its members or former
members in accordance with their interest in the limited liability company,
(iv) any pledge of Stockholder Stock made pursuant to a BONA FIDE loan
transaction that creates a mere security interest, or (v) any BONA FIDE gift;
PROVIDED that in the event of any transfer made pursuant to one of the
exemptions provided by clauses (ii), (iii), (iv) and (v), (A) the Stockholder
shall inform the other Stockholders and the Company of such pledge, transfer
or gift prior to effecting it and (B) the pledgee, transferee or donee shall
furnish the other Stockholders and the Company with a written agreement to be
bound by and comply with all provisions of Section 2. Except with respect to
Stockholder Stock transferred under clause (i) above (which Stockholder Stock
shall no longer be subject to the right of first refusal and co-sale rights
of the Investors), such transferred Stockholder Stock shall remain
"STOCKHOLDER STOCK" hereunder, and such pledgee, transferee or donee shall be
treated as a "STOCKHOLDER" for purposes of this Agreement.
(b) Notwithstanding the foregoing, the provisions of Section 2 shall not
apply to the sale of any Stockholder Stock to the public pursuant to a
registration statement filed with, and declared effective by, the Securities
and Exchange Commission under the Securities Act of 1933, as amended (the
"SECURITIES ACT").
(c) This Agreement is subject to, and shall in no manner limit the right
which the Company may have to repurchase securities from a Stockholder
pursuant to a stock restriction agreement, the Company's Bylaws or other
agreement between the Company and the Stockholder.
4. PROHIBITED TRANSFERS.
(a) In the event that a Stockholder should Transfer any Stockholder
Stock in contravention of the co-sale rights of each Investor under this
Agreement (a "PROHIBITED TRANSFER"), each Investor, in addition to such other
remedies as may be available at law, in
5.
equity or hereunder, shall have the put option provided below, and such
Selling Stockholder shall be bound by the applicable provisions of such
option.
(b) In the event of a Prohibited Transfer, each Investor shall have
the right to sell to such Selling Stockholder the type and number of shares
of Common Stock equal to the number of shares each Investor would have been
entitled to transfer to the purchaser under Section 2.4 hereof had the
Prohibited Transfer been effected pursuant to and in compliance with the
terms hereof. Such sale shall be made on the following terms and conditions:
(i) The price per share at which the shares are to be sold to the
Selling Stockholder shall be equal to the price per share paid by the
purchaser to such Selling Stockholder in such Prohibited Transfer. The
Selling Stockholder shall also reimburse each Investor for any and all fees
and expenses, including legal fees and expenses, incurred pursuant to the
exercise or the attempted exercise of the Investor's rights under Section 2.3.
(ii) Within ninety (90) days after the date on which an Investor
received notice of the Prohibited Transfer or otherwise became aware of the
Prohibited Transfer, such Investor shall, if exercising the option created
hereby, deliver to the Selling Stockholder the certificate or certificates
representing shares to be sold, each certificate to be properly endorsed for
transfer.
(iii) Such Selling Stockholder shall, upon receipt of the
certificate or certificates for the shares to be sold by an Investor,
pursuant to this Section 4(b), pay the aggregate purchase price therefor and
the amount of reimbursable fees and expenses, as specified in Section
4(b)(i), in cash or by other means acceptable to the Investor.
(c) Notwithstanding the foregoing, any attempt by a Selling
Stockholder to transfer Stockholder Stock in violation of Section 2.2 or 2.3
hereof shall be voidable at the option of a majority in interest the
Stockholders (with respect to Section 2.2), or a majority in interest of the
Investors (with respect to 2.3) if the Investors do not elect to exercise the
put option set forth in this Section 4, and the Company agrees it will not
effect such a transfer nor will it treat any alleged transferee as the holder
of such shares without the written consent of a majority in interest of the
Investors.
5. LEGEND.
(a) Each certificate representing shares of Stockholder Stock now or
hereafter owned by the Stockholder or issued to any person in connection with
a transfer pursuant to Section 3(a) hereof (other than clause (i) thereof)
shall be endorsed with the following legend:
"THE SALE, PLEDGE, HYPOTHECATION OR TRANSFER OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO THE TERMS AND
CONDITIONS OF A CERTAIN RIGHT OF FIRST OFFER AND CO-SALE
AGREEMENT BY AND BETWEEN THE SHAREHOLDER, THE COMPANY AND
CERTAIN HOLDERS OF STOCK OF THE COMPANY. COPIES OF SUCH
AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE
SECRETARY OF THE COMPANY."
6.
(b) The Stockholders agree that the Company may instruct its transfer
agent to impose transfer restrictions on the shares represented by
certificates bearing the legend referred to in Section 5(a) above to enforce
the provisions of this Agreement and the Company agrees to promptly do so.
The legend shall be removed upon termination of this Agreement.
6. MISCELLANEOUS.
(a) CONDITIONS TO EXERCISE OF RIGHTS. Exercise of the Stockholders'
rights under this Agreement shall be subject to and conditioned upon, and the
other Stockholders and the Company shall use their best efforts to assist
each Stockholder in, compliance with applicable laws.
(b) GOVERNING LAW. This Agreement shall be governed by and construed
under the laws of the State of California as applied to agreements among
California residents entered into and to be performed entirely within
California.
(c) AMENDMENT. Any provision of this Agreement may be amended and the
observance thereof may be waived (either generally or in a particular
instance and either retroactively or prospectively), only by the written
consent of (i) as to the Company, only by the Company, (ii) as to the
Investors, by persons holding more than sixty-six and two-thirds percent (66
2/3%) in interest of the Common Stock held by the Investors and their
assignees, pursuant to Section 6(d) hereof, and (iii) as to the Stockholders,
only by persons holding more than sixty-six and two-thirds percent (66 2/3%)
in interest of the Common Stock held by the Stockholders (including any
Investor) and their assignees, pursuant to Section 6(d) hereof; provided,
that no consent of any Stockholder shall be necessary for any amendment
and/or restatement which includes additional holders of Common Stock,
Preferred Stock or other preferred stock of the Company as "Stockholders"
and/or "Investors" and parties hereto. Any amendment or waiver effected in
accordance with clauses (i), (ii), and (iii) of this Section 6(c) shall be
binding upon the Company and each Stockholder and their respective successors
and assigns.
(d) ASSIGNMENT OF RIGHTS. This Agreement constitutes the entire
agreement between the parties relative to the specific subject matter hereof.
Any previous agreement, including the Prior Agreement, among the parties
relative to the specific subject matter hereof is superseded by this
Agreement. This Agreement and the rights and obligations of the parties
hereunder shall inure to the benefit of, and be binding upon, their
respective successors, assigns and legal representatives.
(e) TERM. This Agreement shall continue in full force and effect from
the date hereof through the earliest of the following dates, on which date it
shall terminate in its entirety:
(i) the date of the closing of a firmly underwritten
public offering of the Common Stock pursuant to a registration statement
filed with the Securities and Exchange Commission, and declared effective
under the Securities Act of 1933, as amended;
(ii) the date of the closing of a sale, lease, or other
disposition of all or substantially all of the Company's assets or the
Company's merger into or consolidation with any other corporation or other
entity, or any other corporate reorganization, in which the holders of the
Company's outstanding voting stock immediately prior to such transaction own,
7.
immediately after such transaction, securities representing less than fifty
percent (50%) of the voting power of the corporation or other entity
surviving such transaction, PROVIDED that this Section 6(e)(ii) shall not
apply to a merger effected exclusively for the purpose of changing the
domicile of the Company; or
(iii) the date as of which the parties hereto terminate this
Agreement by written consent of at least sixty-six and two-thirds percent (66
2/3%) in interest of the Investors and at least sixty-six and two-thirds
percent (66 2/3%) in interest of the Stockholders.
(f) OWNERSHIP. Each Stockholder represents and warrants that it is the
sole legal and beneficial owner of those shares of Stockholder Stock
currently held by such Stockholder subject to the Agreement and that no other
person has any interest (other than a community property interest) in such
shares.
(g) NOTICES. All notices required or permitted hereunder shall be in
writing and shall be deemed effectively given: (i) upon personal delivery to
the party to be notified, (ii) when sent by confirmed telex or facsimile if
sent during normal business hours of the recipient; if not, then on the next
business day, (iii) five (5) days after having been sent by registered or
certified mail, return receipt requested, postage prepaid, or (iv) one (1)
day after deposit with a nationally recognized overnight courier, specifying
next day delivery, with written verification of receipt. All communications
shall be sent to the party to be notified at the address as set forth on
Exhibit A or Exhibit B hereto, as applicable, or at such other address as
such party may designate by ten (10) days advance written notice to the other
parties hereto.
(h) SEVERABILITY. In the event one or more of the provisions of this
Agreement should, for any reason, be held to be invalid, illegal or
unenforceable in any respect, such invalidity, illegality, or
unenforceability shall not affect any other provisions of this Agreement, and
this Agreement shall be construed as if such invalid, illegal or
unenforceable provision had never been contained herein.
(i) ATTORNEYS' FEES. In the event that any suit or action is
instituted to enforce any provision in this Agreement, the prevailing party
in such dispute shall be entitled to recover from the losing party all fees,
costs and expenses of enforcing any right of such prevailing party under or
with respect to this Agreement, including without limitation, such reasonable
fees and expenses of attorneys and accountants, which shall include, without
limitation, all fees, costs and expenses of appeals.
(j) ENTIRE AGREEMENT. This Agreement and the Exhibits hereto, along
with the Purchase Agreement and each of the Exhibits thereto, constitute the
full and entire understanding and agreement between the parties with regard
to the subjects hereof and thereof and no party shall be liable or bound to
any other in any manner by any representations, warranties, covenants and
agreements except as specifically set forth herein and therein.
(k) ADDITIONAL INVESTORS. Notwithstanding anything to the contrary
contained herein, if the Company shall issue additional shares of its
Preferred Stock pursuant to the Purchase Agreement, any purchaser of such
shares of Preferred Stock may become a party to this
8.
Agreement by executing and delivering an additional counterpart signature
page to this Agreement and shall be deemed an "INVESTOR" hereunder.
(l) COUNTERPARTS. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
9.
The foregoing THIRD AMENDED AND RESTATED RIGHT OF FIRST OFFER AND
CO-SALE AGREEMENT is hereby executed as of the date first above written.
COMPANY: INVESTORS:
ELITRA PHARMACEUTICALS INC. INCYTE GENOMICS, INC.
/s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇ /s/ ▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
----------------------------- ---------------------------------------
By: ▇▇. ▇▇▇▇▇ ▇. ▇▇▇▇▇▇ By: ▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
------------------------------------
Title: President Title: Chief Executive Officer
----------------------------------
LG CHEMICAL LTD.
---------------------------------------
By:
Title:
ENTERPRISE PARTNERS IV, L.P.
/s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
Title: General Partner
ENTERPRISE PARTNERS IV ASSOCIATES, L.P.
/s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
Title: General Partner
▇▇▇▇▇▇▇▇ ASSOCIATES FUND III, a
California Limited Partnership
By: ▇▇▇▇▇▇▇▇ VIII MANAGEMENT, LLC., a
Delaware Limited Liability Company, its
General Partner
/s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
Title: General Partner
SIGNATURE PAGE TO
THIRD AMENDED AND RESTATED RIGHT OF FIRST OFFER AND CO-SALE AGREEMENT
▇▇▇▇▇▇▇▇ VIII, a California Limited
Partnership
By: ▇▇▇▇▇▇▇▇ VIII MANAGEMENT, LLC., a
Delaware Limited Liability Company, its
General Partner
/s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
Title: General Partner
▇▇▇▇▇▇ LIVING TRUST
/s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
Title: Trustee
PATHO TRUST
/s/ ▇▇▇▇▇ ▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇ ▇▇▇▇
-----------------------------------
Title: Administrative Trustee
---------------------------------
▇▇▇▇▇▇-SBIC, L.P.
/s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
-----------------------------------
Title: General Partner
---------------------------------
WIG-GLOBAL VENTURES PTE. LTD.
/s/ Lip-Bu Tan
---------------------------------------
By: Lip-Bu Tan
------------------------------------
Title: Director
--------------------------------
INTERNATIONAL VENTURES CAPITAL
INVESTMENT CORP.
/s/ Lip-Bu Tan
---------------------------------------
By: Lip-Bu Tan
------------------------------------
Title: President
--------------------------------
SIGNATURE PAGE TO
THIRD AMENDED AND RESTATED RIGHT OF FIRST OFFER AND CO-SALE AGREEMENT
PACVEN ▇▇▇▇▇▇ VENTURES IV, L.P.
/s/ Lip-Bu Tan
---------------------------------------
By: Lip-Bu Tan
-----------------------------------
Title: Director of Pacven ▇▇▇▇▇▇
Management Co., Ltd. as General
Partner of Pacven ▇▇▇▇▇▇
Management III, L.P. as General
Partner of Pacven ▇▇▇▇▇▇
Ventures IV, L.P.
PACVEN ▇▇▇▇▇▇ VENTURES IV ASSOCIATES
FUND, L.P.
/s/ Lip-Bu Tan
---------------------------------------
By: Lip-Bu Tan
------------------------------------
Title: Director of Pacven ▇▇▇▇▇▇
Management Co., Ltd. as General
Partner of Pacven ▇▇▇▇▇▇
Ventures IV Associates Fund.,
L.P.
INTERWEST PARTNERS VI, L.P.
By: InterWest Management Partners VI,
LLC
Its: General Partner
/s/ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇▇ ▇▇▇▇▇▇▇, Managing Director
INTERWEST INVESTORS VI, LP
By: InterWest Management Partners VI,
LLC
Its: General Partner
/s/ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇▇ ▇▇▇▇▇▇▇, Managing Director
GENECHEM TECHNOLOGIES VENTURE FUND, L.P.
/s/ ▇▇▇▇▇ ▇▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇ ▇▇▇▇▇▇▇
Title: President
TECHAMP INTERNATIONAL, L.P.
/s/ illegible
---------------------------------------
By:
------------------------------------
Title: Vice President
---------------------------------
SIGNATURE PAGE TO
THIRD AMENDED AND RESTATED RIGHT OF FIRST OFFER AND CO-SALE AGREEMENT
▇▇▇▇▇▇▇ FAMILY, LIMITED PARTNERSHIP
/s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
------------------------------------
Title: Member oF Gen. Part.
---------------------------------
/s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
---------------------------------------
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
BEAR PAW CAPITAL LLC
/s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
------------------------------------
Title: Manager
--------------------------------
THE SEARS LIVING TRUST DTD 3/11/91
/s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇
Title: Trustee
COMDISCO, INC.
/s/ ▇▇▇▇ ▇. ▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇ ▇. ▇▇▇▇▇▇
------------------------------------
Title: Senior Vice President
----------------------------------
U.S. BANCORP ▇▇▇▇▇ ▇▇▇▇▇▇▇ ECM FUND I,
LLC
/s/ ▇▇▇▇ ▇. ▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇ ▇. ▇▇▇▇▇▇
----------------------------------
Title: Managing Director
--------------------------------
/s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇
---------------------------------------
▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇
▇▇▇▇▇▇ ▇▇▇▇ PARTNERS, LLC
/s/ illegible
---------------------------------------
By:
------------------------------------
Title: CEO
---------------------------------
SIGNATURE PAGE TO
THIRD AMENDED AND RESTATED RIGHT OF FIRST OFFER AND CO-SALE AGREEMENT
ALEXANDRIA REAL ESTATE EQUITIES, L.P.
By: ARE-QRS CORP., a Maryland
corporation, general partner
/s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇
------------------------------------
Title: Senior Vice President, Business
Development & Legal Affairs
▇▇▇▇▇▇▇▇ FAMILY TRUST
/s/ ▇▇▇▇ ▇▇▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇ ▇▇▇▇▇▇▇▇
------------------------------------
Title: Trustee
--------------------------------
▇▇▇▇▇▇ LIVING TRUST
/s/ ▇▇▇▇▇▇ ▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇▇ ▇▇▇▇▇▇
----------------------------------
Title: Trustee
---------------------------------
▇▇▇▇▇▇▇▇ FAMILY TRUST UTD 5/8/80
/s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
-----------------------------------
Title: Trustee
--------------------------------
▇▇▇▇▇▇▇▇▇ TRUST, UTD 1/30/99
/s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
---------------------------------------
/s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ and ▇▇▇▇▇ ▇.
▇▇▇▇▇▇▇▇▇
------------------------------------
Title: Trustees
--------------------------------
/s/ Maarten Chrispeels
---------------------------------------
MAARTEN CHRISPEELS
THE ▇▇▇▇▇ FAMILY TRUST
/s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇
--------------------------------
Title: Trustee
--------------------------------
SIGNATURE PAGE TO
THIRD AMENDED AND RESTATED RIGHT OF FIRST OFFER AND CO-SALE AGREEMENT
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ LIVING TRUST
/s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇, Trustee
------------------------------------
/s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇
---------------------------------------
▇▇▇▇▇▇▇ ▇▇▇▇▇
YALTA INVESTMENTS, L.P.
/s/ ▇▇▇ ▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇ ▇▇▇▇▇▇
-----------------------------------
Title: General Partner
--------------------------------
PACIFIC VENTURE GROUP II, L.P.
By: PVG EQUITY PARTNERS II, L.L.C.
Its: General Partner
/s/ ▇▇▇▇▇ ▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇ ▇▇▇▇▇
---------------------------------
Title: Managing Director
---------------------------------
PVG ASSOCIATES II, L.P.
By: PVG EQUITY PARTNERS II, L.L.C.
Its: General Partner
/s/ ▇▇▇▇▇ ▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇ ▇▇▇▇▇
---------------------------------
Title: Managing Director
VLG INVESTMENTS 1998
---------------------------------------
By:
---------------------------------
Title:
---------------------------------
SENVEST INTERNATIONAL LLC
/s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇
---------------------------------
Title: President
---------------------------------
SIGNATURE PAGE TO
THIRD AMENDED AND RESTATED RIGHT OF FIRST OFFER AND CO-SALE AGREEMENT
SENVEST MASTER FUND L.P.
/s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇
---------------------------------------
By: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇
---------------------------------
Title: General Partner
---------------------------------
/s/ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇
---------------------------------------
▇▇▇▇▇▇ ▇▇▇▇▇▇▇
/s/ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇
---------------------------------------
▇▇▇▇▇ ▇▇▇▇▇▇▇▇
/s/ ▇▇▇▇▇ ▇▇▇▇▇▇
---------------------------------------
▇▇. ▇▇▇▇▇ ▇▇▇▇▇▇
GC&H INVESTMENTS
By:
---------------------------------
Title:
---------------------------------
COMMON STOCKHOLDERS:
/s/ ▇▇▇▇▇ ▇▇▇▇▇▇
----------------------------
▇▇. ▇▇▇▇▇ ▇▇▇▇▇▇
----------------------------
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇, Ph.D.
----------------------------
R. ▇▇▇▇▇ ▇▇▇▇▇▇▇, Ph.D.
----------------------------
▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇, M.D.
----------------------------
▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇
----------------------------
Virginia ▇▇▇ ▇▇▇▇▇▇▇▇
SIGNATURE PAGE TO
THIRD AMENDED AND RESTATED RIGHT OF FIRST OFFER AND CO-SALE AGREEMENT
▇▇▇▇▇▇-▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ TRUST
By: /s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇
----------------------------
▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇
Title: Trustee
▇▇▇▇▇ ▇. ▇▇▇▇▇▇ III TRUST
By: /s/ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇
----------------------------
▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇
Title: Trustee
-------------------------------
▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇
-------------------------------
▇▇▇▇▇▇ ▇▇▇▇▇▇ Vest
▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ TRUST
By:
----------------------------
Name:
--------------------------
Title: Trustee
SIGNATURE PAGE TO
THIRD AMENDED AND RESTATED RIGHT OF FIRST OFFER AND CO-SALE AGREEMENT
EXHIBIT A
LIST OF INVESTORS
STOCKHOLDER STOCK
---------------------------------------------------------------------------------
SERIES A SERIES B SERIES C SERIES D SERIES E
------------ -------------- --------------- -------------- -------------
Enterprise Partners IV Associates, L.P. 180,000 320,000 - - - - - - 24,615
▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇
▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Enterprise Partners IV, L.P. 2,070,001 3,680,000 - - - - - - 283,077
▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇
▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Mayfield Associates Fund III 112,500 200,000 - - - - - - 15,385
▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇
▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Mayfield VIII 2,137,501 3,800,000 - - - - - - 292,307
▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇
▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
VLG Investments 1998 15,151 - - - - - - - - - - - -
Attention: ▇▇▇▇ ▇▇▇▇▇▇▇▇▇
▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇
▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
GC&H Investments 30,303 - - - - - - - - - - - -
Attention: ▇▇▇▇ ▇. ▇▇▇▇▇▇▇
▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇
▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
International Ventures Capital Investment Corp. - - - 266,667 - - - - - - 14,480
(▇▇▇▇▇▇)
▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇
▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Pacven ▇▇▇▇▇▇ Ventures IV Associates Fund, L.P. - - - 67,100 - - - - - - 3,643
▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇
▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Pacven ▇▇▇▇▇▇ Ventures IV, L.P. - - - 3,599,567 - - - - - - 195,450
▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇
▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
STOCKHOLDER STOCK
---------------------------------------------------------------------------------
SERIES A SERIES B SERIES C SERIES D SERIES E
------------ -------------- --------------- -------------- -------------
▇▇▇▇▇▇-SBIC, L.P. - - - 1,333,333 - - - - - - 72,400
▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇
▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
WIG-Global Ventures PTE. Ltd. - - - 400,000 - - - - - - 21,719
▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇
▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Interwest Partners - - - 4,848,000 - - - - - - 298,336
▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇
▇▇▇▇▇▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇
▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Interwest Investors - - - 152,000 - - - - - - 9,354
▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇
▇▇▇▇▇▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇
▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
GeneChem Technologies Venture Fund, L.P. - - - 1,333,333 - - - - - - 307,692
1001, de Maisonneuve, ▇▇▇▇
▇▇▇▇▇ ▇▇▇
▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇ #▇▇ ▇▇▇
▇▇▇▇▇▇
▇▇▇▇▇▇▇ Family, Limited Partnership - - - 333,333 - - - - - - 230,769
▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ - - - 66,666 - - - - - - 61,538
▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇
▇▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇
▇▇▇▇▇ ▇▇▇▇▇▇▇▇ - - - 266,666 - - - - - - 123,076
▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇
▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
▇▇. ▇▇▇▇▇ ▇▇▇▇▇▇ - - - 666,666 - - - - - - 400,000
Separate Property Trust
▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇
▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇
STOCKHOLDER STOCK
---------------------------------------------------------------------------------
SERIES A SERIES B SERIES C SERIES D SERIES E
------------ -------------- --------------- -------------- -------------
LG Chemical Ltd - - - - - - 1,041,667 - - - - - -
LG Twin Tower, ▇▇
▇▇▇▇▇-▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇-▇▇, ▇▇▇▇▇
▇▇▇-▇▇▇, ▇▇▇▇▇
Incyte Genomics, Inc. - - - - - - - - - 1,538,462 615,384
▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇
▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇
TechAMP International, L.P. - - - - - - - - - - - - 307,692
AM ▇▇▇▇▇▇ & Associates
Headquarters Park - Beta Bldg.
Suite 420
▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇ - ▇▇▇▇▇▇ ▇▇▇▇▇▇▇
▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Bear Paw Capital LLC - - - - - - - - - - - - 212,307
The ▇▇▇▇▇▇▇ Group
▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
▇▇▇▇▇▇ Living Trust - - - - - - - - - - - - 15,384
Mayfield Fund
▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇
▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Patho Trust - - - - - - - - - - - - 144,615
Mayfield Fund
▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇
▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
The Sears Living Trust Dtd 3/11/91 - - - - - - - - - - - - 38,461
c/o ▇▇▇▇▇▇ ▇▇▇▇▇
Sears Capital Management, Inc.
▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇
▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇
Comdisco, Inc. - - - - - - - - - - - - 153,846
▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇
▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Attn: Venture Group
STOCKHOLDER STOCK
---------------------------------------------------------------------------------
SERIES A SERIES B SERIES C SERIES D SERIES E
------------ -------------- --------------- -------------- -------------
U.S. Bancorp ▇▇▇▇▇ ▇▇▇▇▇▇▇ ECM Fund I, LLC - - - - - - - - - - - - 615,384
▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇
▇▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Attn: ▇▇▇▇ ▇▇▇▇▇▇▇
Senior Business Analyst
▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇ - - - - - - - - - - - - 153,846
▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇
▇▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇
▇▇▇▇▇▇ ▇▇▇▇ Partners, LLC - - - - - - - - - - - - 615,384
▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇
▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇
Alexandria Real Estate Equities, L.P. - - - - - - - - - - - - 76,923
▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇
▇▇▇▇▇ ▇▇▇
▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
The ▇▇▇▇▇▇▇▇ Family Trust - - - - - - - - - - - - 76,923
▇▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇
▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇
The ▇▇▇▇▇▇ Living Trust - - - - - - - - - - - - 50,000
▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇
▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
▇▇▇▇▇▇▇▇ Family Trust UTD 5/8/80 - - - - - - - - - - - - 169,231
▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇▇▇
▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇, ▇▇ ▇▇▇▇▇
▇▇▇▇▇▇▇▇▇ Trust, UTD 1/30/99 - - - - - - - - - - - - 30,800
▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇
▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Maarten Chrispeels - - - - - - - - - - - - 30,770
UCSD
Dept. of Biology
▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇
▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇
STOCKHOLDER STOCK
---------------------------------------------------------------------------------
SERIES A SERIES B SERIES C SERIES D SERIES E
------------ -------------- --------------- -------------- -------------
The ▇▇▇▇▇ Family Trust - - - - - - - - - - - - 153,846
Utonica
▇▇▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇▇
▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ Living Trust - - - - - - - - - - - - 76,923
▇.▇. ▇▇▇ ▇▇▇
▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇
▇▇▇▇▇▇▇ ▇▇▇▇▇ - - - - - - - - - - - - 30,769
▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇
▇▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Yalta Investments, L.P. - - - - - - - - - - - - 30,769
▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇
▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇
Attn: ▇▇▇ ▇. ▇▇▇▇▇▇
Pacific Venture Group II, L.P. - - - - - - - - - - - - 597,260
▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇
▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
PVG Associates II, L.P. - - - - - - - - - - - - 18,124
▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇
▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Senvest International LLC - - - - - - - - - - - - 76,923
▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇ ▇▇▇
Senvest Master Fund L.P. - - - - - - - - - - - - 46,153
▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇ ▇▇▇
▇▇▇▇▇▇ ▇▇▇▇▇▇▇ - - - - - - - - - - - - 30,769
▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇
▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇
EXHIBIT B
CERTAIN HOLDERS OF COMMON STOCK
STOCKHOLDER STOCKHOLDER STOCK
----------- -----------------
▇▇. ▇▇▇▇▇ ▇▇▇▇▇▇ 1,200,000
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇, Ph.D. 880,000
R. ▇▇▇▇▇ ▇▇▇▇▇▇▇, Ph.D. 345,000
▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇, M.D. 5,000
▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇ 20,000
▇▇▇▇▇ ▇. ▇▇▇▇▇▇ III Trust 20,000
▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ Trust 20,000
▇▇▇▇▇▇ ▇▇▇▇▇▇ Vest 20,000
▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇ 20,000
Virginia ▇▇▇ ▇▇▇▇▇▇▇▇ 20,000
▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ Trust 20,000